Masitinib in Combination With Methotrexate, in Treatment of Patients With Active Rheumatoid Arthritis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2009
A 12-week with possible extension, phase II study to compare efficacy and safety of masitinib at 3 and 6 mg/kg/day in combination with methotrexate, in treatment of patients with active rheumatoid arthritis refractory to standard treatments.
Epistemonikos ID: f3ded4be6403a9db04c70ee5e0e261cd99915df3
First added on: Mar 23, 2022